Description
- The double marker test is carried out along with the NT scan, an ultrasound in which measurements are taken for the Nuchal fold of the foetus. The double marker test results are interpreted on the basis of these measurements. This test helps detect chromosomal abnormalities such as Down syndrome, Edwards syndrome, and Patau syndrome. It measures two key biomarkers, free Beta hCG and PAPP-A, present in maternal blood. The double marker test report provides a risk assessment based on these valu
The double marker test is carried out along with the NT scan, an ultrasound in which measurements are taken for the Nuchal fold of the foetus. The double marker test results are interpreted on the basis of these measurements. This test helps detect chromosomal abnormalities such as Down syndrome, Edwards syndrome, and Patau syndrome. It measures two key biomarkers, free Beta hCG and PAPP-A, present in maternal blood. The double marker test report provides a risk assessment based on these values. A low-risk result indicates a lower probability of chromosomal anomalies, whereas a high-risk result may require further testing, such as NIPT or amniocentesis. It is commonly recommended for women above 35 or those with a history of genetic disorders.
Track and manage your health better with SAMPLE REPORT
Description
- The double marker test is carried out along with the NT scan, an ultrasound in which measurements are taken for the Nuchal fold of the foetus. The double marker test results are interpreted on the basis of these measurements. This test helps detect chromosomal abnormalities such as Down syndrome, Edwards syndrome, and Patau syndrome. It measures two key biomarkers, free Beta hCG and PAPP-A, present in maternal blood. The double marker test report provides a risk assessment based on these valu
The double marker test is carried out along with the NT scan, an ultrasound in which measurements are taken for the Nuchal fold of the foetus. The double marker test results are interpreted on the basis of these measurements. This test helps detect chromosomal abnormalities such as Down syndrome, Edwards syndrome, and Patau syndrome. It measures two key biomarkers, free Beta hCG and PAPP-A, present in maternal blood. The double marker test report provides a risk assessment based on these values. A low-risk result indicates a lower probability of chromosomal anomalies, whereas a high-risk result may require further testing, such as NIPT or amniocentesis. It is commonly recommended for women above 35 or those with a history of genetic disorders.